Hill February 1, 2024
The fight over Medicare drug price negotiation picked back up this week with oral arguments in AstraZeneca’s lawsuit and the federal government sending out its first offers for a maximum fair price to manufacturers.
AstraZeneca gave its first oral arguments in the District Court of Delaware on Wednesday. Like other companies and pharmaceutical entities, the drugmaker has alleged a host of constitutional violations resulting from the Medicare drug price negotiation program established by the Inflation Reduction Act.
U.S. District Judge Colm Connolly, chief judge of the District of Delaware, expressed skepticism over AstraZeneca’s argument Wednesday, saying he didn’t understand how the company would lose property due to taking part in negotiations as it claimed, according to Stat.
...Today's Sponsors
Today's Sponsor